171 related articles for article (PubMed ID: 10435629)
1. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.
Legoix P; Bluteau O; Bayer J; Perret C; Balabaud C; Belghiti J; Franco D; Thomas G; Laurent-Puig P; Zucman-Rossi J
Oncogene; 1999 Jul; 18(27):4044-6. PubMed ID: 10435629
[TBL] [Abstract][Full Text] [Related]
2. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
4. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
Chen YW; Jeng YM; Yeh SH; Chen PJ
Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840
[TBL] [Abstract][Full Text] [Related]
5. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway.
Torbenson M; Lee JH; Choti M; Gage W; Abraham SC; Montgomery E; Boitnott J; Wu TT
Mod Pathol; 2002 Mar; 15(3):189-96. PubMed ID: 11904335
[TBL] [Abstract][Full Text] [Related]
6. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P
J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
[TBL] [Abstract][Full Text] [Related]
8. Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas.
Choi YW; Heath EI; Heitmiller R; Forastiere AA; Wu TT
Mod Pathol; 2000 Oct; 13(10):1055-9. PubMed ID: 11048797
[TBL] [Abstract][Full Text] [Related]
9. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
10. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer.
Miyaki M; Iijima T; Kimura J; Yasuno M; Mori T; Hayashi Y; Koike M; Shitara N; Iwama T; Kuroki T
Cancer Res; 1999 Sep; 59(18):4506-9. PubMed ID: 10493496
[TBL] [Abstract][Full Text] [Related]
11. Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability.
Fukushima H; Yamamoto H; Itoh F; Horiuchi S; Min Y; Iku S; Imai K
J Exp Clin Cancer Res; 2001 Dec; 20(4):553-9. PubMed ID: 11876551
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor.
Fujimori M; Ikeda S; Shimizu Y; Okajima M; Asahara T
Cancer Res; 2001 Sep; 61(18):6656-9. PubMed ID: 11559529
[TBL] [Abstract][Full Text] [Related]
13. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
[TBL] [Abstract][Full Text] [Related]
14. [beta-catenin].
Ogawa K; Yaginuma Y
Nihon Rinsho; 2001 Oct; 59 Suppl 6():161-6. PubMed ID: 11761935
[No Abstract] [Full Text] [Related]
15. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.
Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T
Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951
[TBL] [Abstract][Full Text] [Related]
16. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer.
Clements WM; Wang J; Sarnaik A; Kim OJ; MacDonald J; Fenoglio-Preiser C; Groden J; Lowy AM
Cancer Res; 2002 Jun; 62(12):3503-6. PubMed ID: 12067995
[TBL] [Abstract][Full Text] [Related]
17. Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors.
Wu Y; Renard CA; Apiou F; Huerre M; Tiollais P; Dutrillaux B; Buendia MA
Oncogene; 2002 Feb; 21(10):1518-26. PubMed ID: 11896580
[TBL] [Abstract][Full Text] [Related]
18. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
[TBL] [Abstract][Full Text] [Related]
19. Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma.
Bläker H; Hofmann WJ; Rieker RJ; Penzel R; Graf M; Otto HF
Genes Chromosomes Cancer; 1999 Aug; 25(4):399-402. PubMed ID: 10398436
[TBL] [Abstract][Full Text] [Related]
20. Beta-catenin mutation in carcinoma of the uterine endometrium.
Fukuchi T; Sakamoto M; Tsuda H; Maruyama K; Nozawa S; Hirohashi S
Cancer Res; 1998 Aug; 58(16):3526-8. PubMed ID: 9721853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]